Data / Drug companies / Fluvoxamine maleate
Fluvoxamine maleate: 16 companies and 40 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Fluvoxamine maleate is listed in the FDA National Drug Code Directory by 16 companies, with 40 products in commercial distribution. 33 of the products (82.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; capsule, extended release; tablet, coated, and the newest product started marketing on May 15, 2026.
The request: Get every company that lists fluvoxamine maleate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 40
- Generic (ANDA) products
- 33 (82.5%)
- Application numbers
- 10
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list fluvoxamine maleate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bionpharma Inc. | 7 | tablet; capsule, extended release | Generic drugs (ANDA) | February 7, 2025 |
| Ani Pharmaceuticals, Inc. | 3 | tablet, coated | Authorized generics (NDA) | August 9, 2011 |
| Apotex Corp. | 3 | tablet | Generic drugs (ANDA) | July 10, 2001 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | February 7, 2025 |
| Chartwell RX, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | February 23, 2006 |
| Preferred Pharmaceuticals Inc. | 3 | tablet; tablet, coated | Generic drugs (ANDA) | September 4, 2025 |
| A-S Medication Solutions | 2 | tablet; tablet, coated | Generic drugs (ANDA) | February 7, 2025 |
| Actavis Pharma, Inc. | 2 | capsule, extended release | Generic drugs (ANDA) | August 5, 2014 |
| Ajanta Pharma USA Inc. | 2 | capsule, extended release | Generic drugs (ANDA) | October 17, 2024 |
| AvKARE | 2 | capsule, extended release | Generic drugs (ANDA) | December 4, 2025 |
| Camber Pharmaceuticals, Inc. | 2 | capsule, extended release | Generic drugs (ANDA) | July 30, 2025 |
| Par Health USA, LLC | 2 | capsule, extended release | Generic drugs (ANDA) | March 13, 2013 |
| Remedyrepack Inc. | 2 | tablet, coated | Authorized generics (NDA) | October 7, 2018 |
| Upsher-Smith Laboratories, LLC | 2 | capsule, extended release | Generic drugs (ANDA) | May 15, 2026 |
| American Health Packaging | 1 | tablet | Generic drugs (ANDA) | September 29, 2014 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | July 10, 2001 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 14 | 35% |
| Capsule, extended release | 14 | 35% |
| Tablet, coated | 7 | 17.5% |
| Tablet, film coated | 5 | 12.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 33 | 82.5% |
| Authorized generics (NDA) | 7 | 17.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Serotonin Reuptake Inhibitor | 40 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.